Search Results 661-670 of 17535 for Metformin

  1. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...

  2. A Study to Evaluate Itacitinib for Low Risk Graft-vs-Host Disease (GVHD) - Mayo Clinic

    Itacitinib is an experimental drug with an excellent safety record and appears to have activity as a GVHD treatment. A new blood test can identify patients ...

  3. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  4. Patient Perception of Dorsal Vaginal Graft Urethroplasty for Female Urethral Stricture Disease - Mayo Clinic

    Inclusion Criteria: All female patients who were treated with a dorsal vaginal graft urethroplasty for a urethral stricture. Exclusion Criteria:.

  5. Assessment of the Mechanical Properties of Lung Parenchyma using Magnetic Resonance Elastography - Mayo Clinic

    This new technique is called Magnetic Resonance Elastography (MRE). In this study we will look at the stiffness measurements in humans. Participation ...

  6. Database of All Patients with Peritoneal Surface Malignancies Treated at Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Brexpiprazole (oral route) - Side effects & dosage - Mayo Clinic

    This medicine should not be used to treat behavioral problems in elderly patients who have dementia. Breastfeeding. There are no adequate studies in women for ...

  8. Fulvestrant (intramuscular route) - Mayo Clinic

    Fulvestrant injection is used to treat hormone-receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in ...

  9. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

    The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

  10. Epigenetics and the Origin of Muscle Insulin Resistance in Humans - Mayo Clinic

    The investigators are trying to understand the role of DNA (deoxyribonucleic acid) methylation in insulin resistance in skeletal muscle and blood tissues. DNA ...